Astellas Pharma

PROGRAF

Manufacturer:

Astellas Pharma

Prograf HCPCS:

J7525

HCPCS Code Descriptor:

Tacrolimus, parenteral, 5 mg

Category:

J Code

Prograf NDCs:

00469-3016-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Ampul

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00469-3016-01

About Prograf:

PROGRAF is an Oncology drug manufactured by Astellas Pharma and administered via the Intravenous route of administration. The J Code: J7525 is aligned to the drug PROGRAF.

ACCESS PRICING AND MORE BY REGISTERING

J7525 Added Date:

January 1, 2001

J7525 Effective Date:

January 1, 2001

J7525 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Prograf billing and coding information.
Prograf patient assistance information can be found through Astellas Cares at the URL: https://www.prograf.com/savings-information
PROGRAF prescribing information can be found at the link below:
Information regarding PROGRAF’s side effects can be found at MedlinePlus